MM

Mohammad Moqueem Uddin

Active Director Additional Director DIN 02722381
DIN 02722381 First appointment Jul 2009 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Moqueem Uddin

Data last updated:

Mohammad Moqueem Uddin is an Additional Director at Astelead Life Sciences Private Limited (since 2009). The company operates in Healthcare.

DIN 02722381
Primary Designation Additional Director
Industry Healthcare
First Appointment 31 Jul 2009
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director31 Jul 20092009Under Process Of Striking Off

Board colleagues of Mohammad Moqueem Uddin

Directorship timeline

Open interactive timeline →
Astelead Life Sciences Private Limited
Premium access

Shareholding and investment profile for Mohammad Moqueem Uddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Moqueem Uddin

Mohammad Moqueem Uddin currently holds 1 directorship: Astelead Life Sciences Private Limited (Additional Director, since 31 Jul 2009).

Mohammad Moqueem Uddin was first appointed on 31 Jul 2009 as Additional Director at Astelead Life Sciences Private Limited.

The current boards of Mohammad Moqueem Uddin's companies include Md Azhar Hassan (Astelead Life Sciences Private Limited), Nishat Parvin (Astelead Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available